Auxotrophic Salmonella typhi as live vaccine

Vaccine. 1988 Apr;6(2):141-5. doi: 10.1016/s0264-410x(88)80017-3.

Abstract

Salmonella typhi 541Ty has deletions at aroA and purA, causing requirement for aromatic metabolites (including p-aminobenzoate) and for adenine. None of 36 volunteers who drank 10(8) to 10(10) bacteria of 541Ty or its Vi-negative mutant 543Ty showed any adverse effect; all gave evidence of cellular immune response but only a few had serum titre increases. S. typhimurium experiments (at the Wellcome Research Laboratories and at Stanford) show that adenine requirement may reduce both bacterial survival in mouse tissues and live-vaccine efficacy. S. typhi attenuated only by block(s) in aromatic biosynthesis may be more effective as oral-route live vaccine.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • 4-Aminobenzoic Acid / biosynthesis
  • Animals
  • Antibodies, Bacterial / biosynthesis
  • Bacterial Vaccines / isolation & purification*
  • Forecasting
  • Genetic Variation
  • Humans
  • Hydroxybenzoates / biosynthesis
  • Immunity, Cellular
  • Mice
  • Salmonella typhi / immunology*
  • Salmonella typhi / metabolism
  • Vaccines, Attenuated / isolation & purification

Substances

  • Antibodies, Bacterial
  • Bacterial Vaccines
  • Hydroxybenzoates
  • Vaccines, Attenuated
  • 2,3-dihydroxybenzoic acid
  • 4-Aminobenzoic Acid